Patents Assigned to THE CHIDLREN'S MEDICAL CENTER CORPORATION
  • Publication number: 20210278418
    Abstract: Described herein are methods and compositions for treating asthma or an allergic disease. Aspects of the invention relate to administering to a subject an agent that targets Notch4. In one embodiment, the agent is an anti-Notch4 antibody.
    Type: Application
    Filed: March 15, 2019
    Publication date: September 9, 2021
    Applicant: THE CHIDLREN'S MEDICAL CENTER CORPORATION
    Inventors: Talal Amine CHATILA, Hani HARB, Mingcan XIA, Amir MASSOUD
  • Patent number: 10105412
    Abstract: Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in Streptococcus pneumoniae. The antigens may be used therapeutically or prophylactically.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: October 23, 2018
    Assignees: Genocea Biosciences, Inc., Chidlren's Medical Center Corporation
    Inventors: Todd Gierahn, Richard Malley